Thomas R. Cox, Aug 2019
It’s with great excitement that we welcome our newest PostDoc to the team, Amelia Parker.
Amelia joins us having returned from a PostDoctoral position at the National Cancer Institute (NCI) at the National Institutes of Health (NIH) in the USA. Prior to this she completed her Ph.D. in the laboratories of Professor Maria Kavallaris and A/Prof Joshua McCarroll at The Children’s Cancer Institute (CCI) in Sydney.
As a biomedical engineer and cancer biologist, Amelia is interested in the importance of the tumour microenvironment, and in particular the extracellular matrix (ECM) in driving tumour progression.
Amelia’s work will focus on the importance of the ECM in Lung Cancer onset and progression.